Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FLUT vs GSK✓SelectedUSD · GSKFLUT vs GSK performance historyLatest closeAs of-4.52%11/17
Stock and ETF performance explorer

FLUT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-52.1%
GSK return
+43.9%
Excess return
-96.0%
Maximum drawdown
-75.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.5%-2.3%-2.2%-4.4%
7D-8.4%-3.0%-5.4%-8.2%
30D0.0%+0.4%-0.4%-0.1%
3M-21.6%-1.2%-20.4%-21.5%
6M-18.2%+0.9%-19.1%-18.3%
YTD-64.9%+4.0%-68.8%-65.2%
1Y-60.5%+7.3%-67.8%-60.9%
3Y-51.2%+57.1%-108.3%-54.7%
5Y-52.1%+43.0%-95.1%-61.2%
All-52.1%+43.9%-96.0%-61.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling